Grant: CIHR Fellowship
McMaster University
$90,000.00
The role of adherent invasive Escherichia coli in the development and progression of intestinal fibrosis associated with Crohn's disease
FY 2010-11
Summary
Inflammatory bowel diseases (IBD) such as Crohns disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases that occur primarily in the gastrointestinal tract. CD is characterized by chronic inflammation, fibrosis and intestinal obstruction that causes diarrhea, vomiting and abdominal pain. CD afflicts both men and women of all age groups, however, the usual onset typically occurs between the ages 15 and 30 years of age. In Canada, more than 200,000 individuals have CD and of these, approximately more than two thirds will have intestinal fibrosis, which requires hospitalization and surgery. Recent reports have shown that people with CD are at an increase risk of developing colon cancer. Being a lifelong disease, CD significantly impacts quality of life through social and economical challenges. Treatment can help with the better control and management of the disease, but presently there is no cure. Several investigators have implicated intestinal bacteria in development of CD. For example, certain pathogenic strains of Escherichia coli have been detected frequently in the intestine of CD patients. Taken together, there is an urgency to gain better insight into the complications associated with CD. In our proposed study, we will investigate the role of a highly pathogenic strain of E. coli in the development and progression of intestinal fibrosis in mice. We believe that this research will enhance our understanding of the underlying mechanisms by which intestinal bacterial pathogens could alter the host's immune defense and cause significant complications in susceptible individuals. CD is notorious for reducing the quality of life for thousands of people annually, thus this research will bring us a closer to the development of better treatment management and control of such debilitating inflammatory bowel diseases.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
214604
Name
Small Cherrie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
The role of adherent invasive Escherichia coli in the development and progression of intestinal fibrosis associated with Crohn's disease
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Crohn'S Disease; Cytokines; Fibrosis; Histology; Immunohistochemistry; Inflammation; Isogenic Mutants; Murine Models; Pathogenic E. Coli; Virulence Factors
Abstract
Inflammatory bowel diseases (IBD) such as Crohns disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases that occur primarily in the gastrointestinal tract. CD is characterized by chronic inflammation, fibrosis and intestinal obstruction that causes diarrhea, vomiting and abdominal pain. CD afflicts both men and women of all age groups, however, the usual onset typically occurs between the ages 15 and 30 years of age. In Canada, more than 200,000 individuals have CD and of these, approximately more than two thirds will have intestinal fibrosis, which requires hospitalization and surgery. Recent reports have shown that people with CD are at an increase risk of developing colon cancer. Being a lifelong disease, CD significantly impacts quality of life through social and economical challenges. Treatment can help with the better control and management of the disease, but presently there is no cure. Several investigators have implicated intestinal bacteria in development of CD. For example, certain pathogenic strains of Escherichia coli have been detected frequently in the intestine of CD patients. Taken together, there is an urgency to gain better insight into the complications associated with CD. In our proposed study, we will investigate the role of a highly pathogenic strain of E. coli in the development and progression of intestinal fibrosis in mice. We believe that this research will enhance our understanding of the underlying mechanisms by which intestinal bacterial pathogens could alter the host's immune defense and cause significant complications in susceptible individuals. CD is notorious for reducing the quality of life for thousands of people annually, thus this research will bring us a closer to the development of better treatment management and control of such debilitating inflammatory bowel diseases.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Small, Cherrie
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~